Table S1. Sociodemographic and clinical characteristics of patients who underwent sestamibi SPECT/CT and MRI with available ccLS and histopathology. Table S2. Diagnostic performance of 99mTc-sestamibi SPECT/CT alone, MRI alone and their combination in preoperative characterisation of cT1a indeterminate renal masses. Fig. S1. Receiver-operating characteristic (ROC) curves displaying the diagnostic performance of SPECT/CT sestamibi alone, MRI alone, and the combination of both modalities in identifying ccRCC, when lesions with a ccLS of 3 are considered as ccRCC (Panel A) and when ccLS 3 lesions are instead categorised as other histologies (Panel B). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Bertini et al. (Tue,) studied this question.